Re: Testosterone Breakthrough Rates during Androgen Deprivation Therapy for Castration Sensitive Prostate Cancer
- PMID: 33026925
- DOI: 10.1097/JU.0000000000001402
Re: Testosterone Breakthrough Rates during Androgen Deprivation Therapy for Castration Sensitive Prostate Cancer
Comment in
-
Reply by Authors.J Urol. 2021 Feb;205(2):345. doi: 10.1097/JU.0000000000001403. Epub 2020 Oct 7. J Urol. 2021. PMID: 33026926 No abstract available.
Comment on
-
Testosterone Breakthrough Rates during Androgen Deprivation Therapy for Castration Sensitive Prostate Cancer.J Urol. 2020 Sep;204(3):416-426. doi: 10.1097/JU.0000000000000809. Epub 2020 Feb 25. J Urol. 2020. PMID: 32096678 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical